|
GlaxoSmithKline Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
44059.12 Cr.
|
P/BV
|
22.58
|
Book Value (Rs.)
|
115.19
|
|
52 Week High/Low (Rs.)
|
3516/1921
|
FV/ML
|
10/1
|
P/E(X)
|
47.36
|
|
Bookclosure
|
30/05/2025
|
EPS (Rs.)
|
54.91
|
Div Yield (%)
|
2.08
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 1255.19 | 959.80 | 841.49 | 2475.65 | 723.10 |
| | | | | | |
| Net CashFlow From Operating Activities | 1289.90 | 582.02 | 484.23 | 810.75 | 577.93 |
| Net Cash Used In Investing Activities | -45.80 | 8.71 | 807.85 | -405.51 | 418.59 |
| Net Cash Used From Financing Activities | -769.42 | -561.50 | -1543.32 | -524.24 | -696.14 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 474.68 | 29.23 | -251.25 | -119.00 | 300.38 |
| Cash And Cash Equivalents Begin of Year | 64.17 | 34.94 | 286.19 | 405.19 | 104.81 |
| Cash And Cash Equivalents End Of Year | 538.85 | 64.17 | 34.94 | 286.19 | 405.19 |